South African billionaire Saltzman family’s Dis-Chem posts $1.2 billion half-year revenue
Dis-Chem Pharmacies, backed by South Africa’s billionaire Saltzman family, posted $1.2 billion revenue in H1 2025, driven by retail and wholesale growth.
Skip to content
Dis-Chem Pharmacies, backed by South Africa’s billionaire Saltzman family, posted $1.2 billion revenue in H1 2025, driven by retail and wholesale growth.
Dis-Chem, backed by South Africa’s Saltzman family, has opened its 300th store in Mbombela, expanding access to affordable primary healthcare.
The Saltzman family’s stake in Dis-Chem has rebounded to nearly $500 million as shares rally on the Johannesburg Stock Exchange (JSE).
Dis-Chem founders lose $28 million as retail stock pressures hit Saltzman family’s holding on the Johannesburg Stock Exchange.
The move involves 217 million shares held via Ivlyn Local Investment Holdings, an investment vehicle controlled by the Saltzman family.
Dis-Chem’s Ivan Saltzman restructures $377.7 million stake, transferring shares to heirs in a move reinforcing family control, succession, and executive alignment.
This increase highlights the family's position as one of South Africa’s wealthiest.
This latest drop comes after a $26.33 million loss earlier in the year.
This comes after a period of growth in 2024, reflecting the group’s resilience last year.
This not only cements the Saltzman family’s status among South Africa’s wealthiest but also underscores Dis-Chem’s strong market performance.
This recent gain follows an earlier increase of $18.79 million between Sept. 13 and Oct. 26.
South Africa’s Saltzman family controls a 29.3 percent stake, equivalent to 302,066,319 ordinary shares in the Gauteng-based company.
This increase follows earlier gains recorded between April 24 and April 30, when the market value of the family’s stake surged by R433.55 million ($23.05 million)
The family’s recent financial gains come after experiencing losses between March 22 and April 18, during which the family’s joint stake in Dis-Chem fell by $44.1 million.
Despite the decline, the Saltzmans remain prominent investors on the Johannesburg Stock Exchange (JSE).